6-111559422-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_147686.4(TRAF3IP2):c.1681C>T(p.Gln561*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000411 in 1,461,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_147686.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461456Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727038
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Candidiasis, familial, 8 Uncertain:1
This sequence change results in a premature translational stop signal in the TRAF3IP2 gene (p.Gln561*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 5 amino acids of the TRAF3IP2 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with TRAF3IP2-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at